GOLSEEK
Live / Applied — Second extension granted (statement of use) (as of 05 Nov 2025)
What this means for you
Not registered yet, but its 10 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98350981
- Mark type
- Stylized text
- Filed
- 10 Jan 2024
- Published for opposition
- 10 Sept 2024
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development relating to pharmaceutical preparations for human use.
Owner
- Bristol-Myers Squibb Company, Princeton, NJ, US
- Bristol-Myers Squibb Company, Princeton, NJ, US
Prosecution history
- 06 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Nov 2025 — SOU EXTENSION 2 GRANTED
- 05 Nov 2025 — SOU EXTENSION 2 FILED
- 05 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Jul 2025 — SOU EXTENSION 1 GRANTED
- 04 May 2025 — SOU EXTENSION 1 FILED
- 11 Jul 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Jun 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 10 Jun 2025 — NOTICE OF REVIVAL - E-MAILED
- 10 Jun 2025 — PETITION TO REVIVE-GRANTED
- 10 Jun 2025 — TEAS PETITION TO REVIVE RECEIVED
- 09 Jun 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 09 Jun 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 05 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT